Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export fund holdings as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export futures history as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export fund holdings as CSV.
Sign in and upgrade to a paid plan to export announcements as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.

Prism Medico and Pharmacy Ltd.

Financial Services · Finance

BSE: 512217
₹28.98
▲ 0.04 (0.14%)
Oct. 5, 2026 · BSE · bse_bhavcopy
Quality
20/100
Weak
Valuation
69/100
Fairly Valued
Momentum
50/100
Neutral

QVM read Mixed signals Quality Weak, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹39 Cr
PE (TTM)
Data unavailable.
Price to Book
2.6
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
31.7
Free Cash Flow
₹0 Cr
as of March 31, 2026
Industry median ₹-0 Cr (536 companies)
EPS Growth (YoY)
300.00%
as of June 30, 2026
Industry median 25.00% (187 companies)
Net Profit Growth (TTM)
-149.69%
as of June 30, 2026
Industry median 0.00% (481 companies)
Operating Revenue Growth (TTM)
13.15%
as of June 30, 2026
Industry median 0.00% (476 companies)
Profit Growth (YoY)
-30.00%
as of Dec. 31, 2025
Industry median 12.66% (188 companies)
Revenue Growth (YoY)
284.93%
as of March 31, 2026
Industry median 8.05% (138 companies)
Current Ratio
77.34
as of March 31, 2026
Industry median 5.29 (212 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.00 (206 companies)
Interest Coverage
-78.71
as of June 30, 2026
Industry median 2.05 (385 companies)
Net Margin
-85.77%
as of March 31, 2026
Industry median 21.71% (183 companies)
Operating Margin (EBIT)
-43.67%
as of March 31, 2026
Industry median 29.93% (192 companies)
Operating Margin (TTM)
-11.28%
as of June 30, 2026
Industry median 31.63% (395 companies)
Return on Assets
-2.24%
as of March 31, 2026
Industry median 0.85% (493 companies)
Return on Capital Employed
2.81%
as of March 31, 2026
Industry median 1.93% (197 companies)
Return on Equity
-2.26%
as of March 31, 2026
Industry median 1.37% (491 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (-2.3%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 5 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.1%
Low 27.1200 · High 30.0000
1W return
2.0%
Low 27.1200 · High 30.0000
1M return
-3.4%
Low 25.3700 · High 31.8000
52W return
18.5%
Low 25.3700 · High 31.8000
Lifetime High ₹81.5000 (April 25, 2011)
Lifetime Low ₹4.7400 (Aug. 26, 2021)

Full price history and technicals →

EMA & SMA

Bullish4
Bearish2
5D
28.9
10D
29.0
20D
29.0
50D
28.0
100D
27.1
200D
27.1

Delivery and volume

Day avg. delivery
85.2%
Week avg. delivery
95.2%
Month avg. delivery
75.8%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

28.70
Pivot
First resistance30.28
Second resistance31.58
Third resistance33.16
First support27.40
Second support25.82
Third support24.52
Day RSI51.4
Day MFI31.2
Day MACD0.22
Day MACD signal0.42

Beta

1M-0.17
3M-0.14
1Y-0.14
3Y0.48

Price change analysis

↓ -3.4%
Over 1 Month
LowHigh
25.3731.80
↑ 18.5%
Over 3 Months
LowHigh
25.3731.80
↑ 18.5%
Over 6 Months
LowHigh
25.3731.80
↑ 18.5%
Over 1 Year
LowHigh
25.3731.80
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹0 Cr
Net profit (June 30, 2026)
₹-0 Cr
Basic EPS (June 30, 2026)
₹0.0400

Ranks #273 of 510 in Finance by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter29.98%

Largest holders

NameCategoryShares %Shares
Dharmender KharbPublic19.3500%2625000
Symbiosis Pharmaceuticals Private LimitedPromoter15.6500%2123083
Galaxy Vitacare Private LimitedPromoter13.2500%1797672
Raju TyagiPublic9.7700%1325000
Sejal S NashatarPublic2.5100%340000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings increased from 25.49% to 29.98% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
8 May 2026 MANTHAN RAMESH HIRANI Bulk Buy 34,611 30.4700 BSE
27 Apr 2026 ANILKUMAR Bulk Sell 43,147 31.9200 BSE
23 Apr 2026 ADITYA BALASARIA (HUF) Bulk Buy 45,500 32.9300 BSE
10 Apr 2026 SUKHA SINGH Bulk Sell 40,700 28.4100 BSE
25 Mar 2026 CHAGANLAL PRAKASH CHAND Bulk Sell 35,039 27.2100 BSE
25 Mar 2026 PRAKASHCHAND MUKESHKUMAR Bulk Sell 43,312 27.2100 BSE
25 Mar 2026 MOUNA MAHAVEER JAIN Bulk Buy 90,000 27.1300 BSE
16 Mar 2026 NISHIKANT SINGH Bulk Sell 32,007 26.9000 BSE
16 Mar 2026 REETA DEVI Bulk Buy 70,896 26.7700 BSE
13 Mar 2026 REETA DEVI Bulk Buy 43,310 25.8200 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from WOOLITE MERCANTILE CO.LTD. to Prism Medico and Pharmacy Ltd.

All corporate actions →

Corporate Announcements

All 5 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
5 Oct 2026 Others Prism Medico and Pharmacy Ltd - 512217 - Compliance-57 (5) : intimation after the end of quarter
30 Sep 2026 Insider Trading / SAST Prism Medico and Pharmacy Ltd - 512217 - Closure of Trading Window
30 Sep 2026 Others Prism Medico and Pharmacy Ltd - 512217 - Compliance-57 (4) : Prior intimation to the beginning of the quarter
19 Sep 2026 AGM/EGM Prism Medico and Pharmacy Ltd - 512217 - Shareholder Meeting / Postal Ballot-Outcome of AGM
19 Sep 2026 Company Update Prism Medico and Pharmacy Ltd - 512217 - Regulation 30(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations, 2015 - Proceedings Of 24Th Annual General Meeting Held On 19Th September, 2026.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Strong revenue growth YoY (284.9%)

Weaknesses

  • Low Return on Equity (-2.3%)
  • Thin net profit margin (-85.8%)
  • Declining profit YoY (-30.0%)

Opportunities

Data unavailable.

Threats

  • Weak interest coverage (-78.7x) -- limited cushion against rising rates

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Prism Medico and Pharmacy Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.